CAS 35256-86-1

Benzipram

Description:

Benzipram, with the CAS number 35256-86-1, is a chemical compound that belongs to the class of tricyclic antidepressants. It is primarily known for its pharmacological properties, particularly its role as a serotonin and norepinephrine reuptake inhibitor, which contributes to its antidepressant effects. Benzipram exhibits a complex structure that includes a bicyclic framework, which is characteristic of many tricyclic compounds. The substance is typically administered in therapeutic settings to manage depressive disorders and may also have applications in treating anxiety. Its mechanism of action involves modulating neurotransmitter levels in the brain, thereby influencing mood and emotional regulation. As with many pharmaceuticals, the safety profile, potential side effects, and interactions with other medications are important considerations in its use. Additionally, the compound's solubility, stability, and bioavailability are critical factors that influence its efficacy and formulation in medicinal products. Overall, Benzipram represents a significant compound in the field of psychopharmacology.

Formula: C₁₉H₂₃NO

InChI: InChI=1S/C19H23NO/c1-14(2)20(13-17-8-6-5-7-9-17)19(21)18-11-15(3)10-16(4)12-18/h5-12,14H,13H2,1-4H3

InChI key: InChIKey=FVLVBVSILSHUAF-UHFFFAOYSA-N

SMILES: C(N(CC1=CC=CC=C1)C(C)C)(=O)C2=CC(C)=CC(C)=C2

Synonyms:

• 3,5-Dimethyl-N-(1-methylethyl)-N-(phenylmethyl)benzamide
• 35256-86-1
• benzamide, 3,5-dimethyl-N-(1-methylethyl)-N-(phenylmethyl)-
• Benzipram
• N-Benzyl-N-isopropyl-3,5-dimethylbenzamid
• N-benzyl-N-isopropyl-3,5-dimethylbenzamide

Benzipram

CAS: 35256-86-1

Benzipram is a potent inhibitor of protein kinases that has shown promising anticancer activity. It was originally isolated from Chinese urine and has been found to induce apoptosis in human cancer cells. Benzipram works by inhibiting the activity of specific kinases that are involved in tumor growth and progression, making it a potential treatment for various types of cancer. In fact, studies have shown that Benzipram is more effective than quetiapine, another kinase inhibitor analog, in inducing apoptosis in cancer cells. This drug may hold great potential as a new class of targeted anticancer agents.

Formula: C₁₉H₂₃NO

Purity: Min. 95%

Molecular weight: 281.4 g/mol

Ref: 3D-KBA25686